Please try another search
Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and intermediates. The Company mainly operates through two segments, including the New Drug and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The New Drug and Intermediates CDMO segment mainly provides services for innovative medicines of pre-clinical chemical manufacturing and controls (CMC), clinical phases I, II and III, new drug application (NDA) and various stages after going public. The Specialty API and Intermediates segments mainly provides services including patent breakthroughs, production process improvement, drug certificate declaration, and cGMP standard commercial production for patented expired or soon-to-be-expired drugs for global chemical and generic drug manufacturers.
Name | Age | Since | Title |
---|---|---|---|
Meng Sheng Sun | 66 | - | Chairman of Supervisory Board |
Lirong Hua | 56 | 2014 | Chairman |
Xiao Hui Hua | 47 | 2014 | Director |
Huilu Lin | 51 | 2014 | VP, Secretary of the Board of Directors & Director |
Yi Jiang Mei | 49 | 2018 | President & Director |
Jicheng Li | 67 | 2020 | Independent Director |
Yujie Sha | 44 | 2021 | Financial Manager, CFO, VP & Director |
Biao Yu | 57 | 2020 | Independent Director |
Qi Jiang | 43 | 2023 | Independent Director |
Ming Xu | 54 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review